340B INDUSTRY LEADER SPOTLIGHT

Jaclyn Hahn, Director of Pharmacy, Ravin Consultants

Jaclyn Hahn

Q: Where did you grow up?

I grew up at the Jersey shore. After college, I moved to Santa Barbara, CA where I lived for 13 years before recently relocating with my family to Sarasota, FL. My Jersey girl accent is long gone these days, but I still love to visit in the summer and spend time with my

Read More »

Two More Drug Companies Restore 340B Contract Pharmacy Access in Arkansas After Court Decision; Enforcement Action Imminent Against Others

As AID prepares to initiate enforcement of Arkansas' 340B contract pharmacy law, two more drugmakers announced they would exempt state providers from their contract pharmacy policies.
Months after nine drug manufacturers restored 340B contract pharmacy access in Arkansas, two more companies have announced they will exempt [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Maryland House Unanimously Passes 340B Contract Pharmacy Bill

Maryland is the sixth state with a 340B contract pharmacy bill to pass at least one legislative chamber this session.
The Maryland state house yesterday unanimously passed a bill that would prohibit drugmaker 340B contract pharmacy restrictions in the state. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Reports Critique Financial Dynamics of 340B Program

Recent reports from 46brooklyn, a nonprofit think tank, and IQVIA, a drug industry analytics firm, criticized the financial dynamics of 340B.
The 340B program may increase medication costs for self-insured employers, a recent study from a pharmaceutical industry outsourcing and analytics [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Hospitals’ Low-Income Prostate Cancer Patients Had Better Adherence

Dr. Kassem Faraj and his co-authors at the University of Michigan found 340B was associated with better treatment adherence for more vulnerable prostate cancer patients.
Although 340B participation did not correlate to the start of costly treatment for men with advanced prostate cancer enrolled in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Mississippi House Passes 340B Contract Pharmacy Bill, Two Days After Senate Passes Similar Bill

The Mississippi House passed, 83-31, a bill that would prohibit drugmaker 340B contract pharmacy restrictions in the state.
The Mississippi state house yesterday passed a bill to bar drugmaker 340B contract pharmacy restrictions and certain 340B-specific pharmacy benefit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Exclusive

Imminent Enforcement of Arkansas 340B Contract Pharmacy Law to Follow Court Decision Upholding It

Arkansas Insurance Department office sign
The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.
After a federal appeals court recently upheld Arkansas’ 340B contract pharmacy law, the state will initiate enforcement against 14 drugmakers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Mississippi Senate Unanimously Passes 340B Contract Pharmacy Bill After Similar Legislation Dies in Florida

The Mississippi state senate unanimously passed a bill to bar drugmaker 340B contract pharmacy restrictions and certain 340B-specific PBM policies.
The Mississippi Senate this week unanimously passed a bill to bar drugmaker 340B contract pharmacy restrictions and certain 340B-specific pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

For Covered Entities, Integrated Care is No Longer an Option

SPONSORED CONTENT

While health leaders have touted the “whole health” approach of integrated healthcare for decades as a way to provide patients with better, more cost-effective care, the COVID-19 pandemic significantly

Read More »

340B Small Share of Drugmaker Revenue, Says Hospital-Backed Report

340B drug discounts only amounted to a small percentage of total drugmaker revenue, a hospital-funded study found.
Despite the increase in the amount of 340B program drug discounts, those only amounted to 3.1% of global and 7% [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live